Variable NAT1 enzyme activity in long-term cultured human HaCat keratinocytes

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 75, Issue 8-10, 2012, Pages 471-477

  Scheitza, Simone ^a   Bonifas, Jutta ^a   Blömeke, Brunhilde ^a  

^a UNIVERSITY OF TRIER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; KERATIN TYPE I; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CELL AGING; CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL;

ARYLAMINE N-ACETYLTRANSFERASE; CELL DIVISION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CYTOLOGICAL TECHNIQUES; FREEZING; HUMANS; ISOENZYMES; KERATIN-1; KERATINOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; TRANSGLUTAMINASES;

EID: 84862556347     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2012.674915     Document Type: Article

References (30)

1. Adam, P. J., Berry, J., Loader, J. A., Tyson, K. L., Craggs, G., Smith, P., De Belin, J., Steers, G., Pezzella, F., Sachsenmeir, K. F., Stamps, A. C., Herath, A., Sim, E., O'Hare, M. J., Harris, A. L., and Terrett, J. A. 2003. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. Mol. Cancer Res. 1: 826-35.
2. Balasubramanian, S., Sturniolo, M. T., Dubyak, G. R., and Eckert, R. L.2005. Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate- dependent differentiation but not apoptosis. Carcinogenesis 26: 1100-8.
3. Bikle, D. D., Ratnam, A., Mauro, T., Harris, J., and Pillai, S. 1996. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J. Clin. Invest. 97: 1085-93.
4. Bonifas, J., Scheitza, S., Clemens, J., and Blomeke, B. 2010a. Characterization of N-acetyltransferase 1 activity in human keratinocytes and modulation by paraphenylenediamine. J. Pharmacol. Exp. Ther. 334: 318-26.
5. Bonifas, J., Hennen, J., Dierolf, D., Kalmes, M., and Blömeke, B. 2010b. Evaluation of cytochrome p450 1 (CYP1) and N-acetyltransferase 1 (NAT1) activities in HaCaT cells: Implications for the development of in vitro techniques for predictive testing of contact sensitizers. Toxicol. In Vitro 24: 973-80.
6. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol. 106: 761-71.
7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-54.
8. Brooke, E. W., Davies, S. G., Mulvaney, A. W., Pompeo, F., Sim, E., and Vickers, R. J. 2003. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases. Bioorg. Med. Chem. 11: 1227-34.
9. Butcher, N. J., Ilett, K. F., and Minchin, R. F. 2000. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol. Pharmacol. 57: 468-73.
10. Foth, H., and Hayes, A. 2008. Background of REACH in EU regulations on evaluation of chemicals. Hum. Exp. Toxicol. 27: 443-61.
11. Ghahary, A., Marcoux, Y., Karimi-Busheri, F., and Tredget, E. E. 2001. Keratinocyte differentiation inversely regulates the expression of involucrin and transforming growth factor beta1. J. Cell. Biochem. 83: 239-48.
12. Gilchrest, B. A. 1983. In vitro assessment of keratinocyte aging. J. Invest. Dermatol. 81(1 suppl.): 184s-89s.
13. Goebel, C., Hewitt, N. J., Kunze, G., Wenker, M., Hein, D. W., Beck, H., and Skare, J. 2009. Skin metabolism of aminophenols: Human keratinocytes as a suitable in vitro model to qualitatively predict the dermal transformation of 4-amino-2-hydroxytoluene in vivo. Toxicol. Appl. Pharmacol. 235: 114-23.
14. Hartung, T., and Daston, G. 2009. Are in vitro tests suitable for regulatory use? Toxicol. Sci. 111: 233-37.
15. Hein, D. W., Rustan, T. D., Ferguson, R. J., Doll, M. A., and Gray, K. 1994. Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol. 68: 129-33.
16. Hennings, H., and Holbrook, K. A. 1983. Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. An ultrastructural study. Exp. Cell. Res. 143: 127-42.
17. Höfer, T., Gerner, I., Gundert-Remy, U., Liebsch, M., Schulte, A., Spielmann, H., Vogel, R., and Wettig, K. 2004. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Arch. Toxicol. 78: 549-64.
18. Kim, S. Y., Chung, S. I.,Yoneda, K., and Steinert, P. M. 1995. Expression of transglutaminase 1 in human epidermis. J. Invest. Dermatol. 104: 211-17.
19. Kirstein, S. L., Atienza, J. M., Xi, B., Zhu, J., Yu, N., Wang, X., Xu, X., and Abassi, Y. A. 2006. Live cell quality control and utility of real-time cell electronic sensing for assay development. Assay Drug Dev. Technol. 4: 545-53.
20. Matsui, M., Miyasaka, J., Hamada, K., Ogawa, Y., Hiramoto, M., Fujimori, R., and Aioi, A. 2000. Influence of aging and cell senescenceon telomerase activity in keratinocytes. J. Dermatol. Sci. 22: 80-87.
21. McKim, J. M., Keller, D. J., and Gorski, J. R. 2010. A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan. Ocul. Toxicol. 29: 171-92.
22. 2+-induced differentiation in HaCaT cells. J. Chromatogr. B. Anal. Technol. Biomed. Life Sci. 878: 1051-58.
23. Pillai, S., Bikle, D. D., Mancianti, M. L., Cline, P., and Hincenbergs, M. 1990. Calcium regulation of growth and differentiation of normal human keratinocytes: Modulation of differentiation competence by stages of growth and extracellular calcium. J. Cell. Physiol. 143: 294-302.
24. Rea, M. A., and Rice, R. H. 2001. Telomerase deregulation in immortalized human epidermal cells: Modulation by cellular microenvironment. Int. J. Cancer 94: 669-73.
25. Riddle, B., and Jencks, W. P. 1971. Acetylcoenzyme A: Arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate. J. Biol. Chem. 246: 3250-58.
26. Rovida, C., and Hartung, T. 2009. Reevaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - A report by the transatlantic think tank for toxicology (t(4)). ALTEX 26: 187-208.
27. Tiang, J. M., Butcher, N. J., and Minchin, R. F. 2010. Small molecule inhibition of arylamine N-acetyltransferase type I inhibits proliferation and invasiveness of MDA-MB- 231 breast cancer cells. Biochem. Biophys. Res. Commun 393: 95-100.
28. Vandebriel, R. J., Pennings, J. L., Baken, K. A., Pronk, T. E., Boorsma, A., Gottschalk, R., and Van Loveren, H. 2010. Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. Toxicol. Sci. 117: 81-89.
29. Wilkening, S., and Bader, A. 2003. Influence of culture time on the expression of drugmetabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J. Biochem. Mol. Toxicol. 17: 207-13.
30. Woodcock-Mitchell, J., Eichner, R., Nelson, W. G., and Sun, T. T. 1982. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell. Biol. 95: 580-88.